{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0000", "char_start": 0, "char_end": 1200, "pages": [1], "text": "November 2022\nVolume 38 | Number 13\nUpdate to New York Independent Assessor Initial Assessment\nProcess\nEffective December 1, 2022, the New York Independent Assessor (NYIA) will begin conducting the initial\nassessment process, as defined in the May 2022 Special Edition issue of the Medicaid Update, located at:\nhttps://www.health.ny.gov/health_care/medicaid/program/update/2022/docs/mu_no5_may22_speced_pr.pdf\n, for adults (18 years of age and older) seeking Personal Care Services (PCS) and/or Consumer Directed\nPersonal Assistance Services (CDPAS) based on immediate need for services.\nIndividuals seeking PCS and/or CDPAS based on an immediate need for those services will now have two\nways to obtain their medical professional’s certification of the need for services:\n1. Individuals can provide their Local Department of Social Services (LDSS) with either a Practitioner\nStatement of Need for Personal Care/Consumer Directed Personal Assistance Services For Adults\n18 and Over (for Immediate Needs) form (DOH-5779), located at: https://www.health.ny.\ngov/forms/doh-5779.pdf, or\n2. Individuals can provide their LCSS with a physician’s order form [Physician’s Order for Personal\nCare/Consumer Dir", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0001", "char_start": 1050, "char_end": 2250, "pages": [1], "text": "h.ny.\ngov/forms/doh-5779.pdf, or\n2. Individuals can provide their LCSS with a physician’s order form [Physician’s Order for Personal\nCare/Consumer Directed Personal Assistance Services form (DOH-4359), located at:\nhttps://www.health.ny.gov/health_care/medicaid/publications/docs/gis/10oltc-006att.pdf or Medical\nRequest for Home Care form (HCSP-M11Q), located at: https://www1.nyc.gov/assets/hra/downloads\n/pdf/services/micsa/m_11q.pdf].\nThe DOH-5779 form requires less documentation from a practitioner and can be completed by a Doctor of\nMedicine (MD), Doctor of Osteopathic Medicine (DO), nurse practitioner (NP), or physician assistant (PA).\nRegardless of whether the individual provides their LDSS a DOH-5779 form (or physician’s order form to\nsubstantiate their immediate need for services), they are still required to have a NYIA Independent Practitioner\nPanel (IPP) clinical appointment and a Practitioner Order completed by an IPP clinician. Once the individual\nprovides their LDSS with a completed Immediate Needs packet, the LDSS will refer their case to NYIA to\nschedule a community health assessment (CHA) and clinical appointment, to be completed in an expedited\ntimeframe.\nPlease note:", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0002", "char_start": 2100, "char_end": 3300, "pages": [1, 2], "text": "r their case to NYIA to\nschedule a community health assessment (CHA) and clinical appointment, to be completed in an expedited\ntimeframe.\nPlease note: This update does not apply to children under 18 years of age. LDSS will continue to perform\nthe assessments for this population and require a physician’s order form (DOH-4359 or HCSP-M11Q).\nQuestions and Additional Information:\n• For more information on the Immediate Needs process under NYIA, please refer to Administrative\nDirective memorandum, located at: https://www.health.ny.gov/health_care/medicaid/publications/\n22adm01.htm.\n• All questions regarding NYIA and this update should be directed to\nindependent.assessor@health.ny.gov.\n***************************************************************************************************************\n\nKathy Hochul\nGovernor\nState of New York\nMary T. Bassett, M.D., M.P.H.\nCommissioner\nNew York State\nDepartment of Health\nAmir Bassiri\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nUpdate to New York Independent Assessor Initial Assessment Process .........................................", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0003", "char_start": 3150, "char_end": 4350, "pages": [2], "text": "tate Department of Health.\nIn This Issue…\nUpdate to New York Independent Assessor Initial Assessment Process .................................................................. Cover\nAll Providers\nReminder: Sign Up for eMedNY Training Webinars .......................................................................................................... 3\neMedNY Provider Training Videos Available ..................................................................................................................... 3\nReminder to Dental Providers on the Use of Antibiotics in Dentistry ................................................................................. 4\nUnderstanding How Adverse Childhood Experiences Affect Patients’ Health Across the Lifespan .................................. 5\nNational Cancer Institute-Designated Cancer Centers ...................................................................................................... 6\nPolicy and Billing\nReminder: Medicaid Billing Rules for Family Planning and Reproductive Health Services ............................................... 7\nSystem Requirements for Compounded Prescriptions ............................................", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0004", "char_start": 4200, "char_end": 5400, "pages": [2, 3], "text": "rvices ............................................... 7\nSystem Requirements for Compounded Prescriptions ...................................................................................................... 8\nMpox (formerly known as Monkeypox) Services No Longer Exempt from Medicaid Copayments ................................... 8\nPharmacy\nUpdates to Medicaid Fee-for-Service Practitioner Administered Drug Policies and Billing Guidance ............................... 9\nReminder: Pharmacy Dispensing of Emergency Contraceptives .................................................................................... 11\nProvider Directory ............................................................................................................................................................. 13\nNovember 2022 New York State Medicaid Update pg. 2\n\nAll Providers\nReminder: Sign Up for eMedNY Training Webinars\neMedNY offers several online training webinars to providers and their billing staff, which can be accessed via\ncomputer and telephone. Valuable provider webinars offered include:\n• Provider Enrollment Portal - Practitioner\n• ePACES for: Dental, Durable Medical Equipment (DME), Institut", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0005", "char_start": 5250, "char_end": 6450, "pages": [3], "text": "aluable provider webinars offered include:\n• Provider Enrollment Portal - Practitioner\n• ePACES for: Dental, Durable Medical Equipment (DME), Institutional, Physician, Private Duty\nNursing, Professional (Real-Time), and Transportation\n• ePACES Dispensing Validation System (DVS) for DME\n• eMedNY Website Review\n• Medicaid Eligibility Verification System (MEVS)\n• New Provider / New Biller\nWebinar registration is fast and easy. To register and view the list of topics, descriptions and available\nsession dates, providers should visit the eMedNY “Provider Training” web page, located at:\nhttps://www.emedny.org/training/index.aspx. Providers are reminded to review the webinar descriptions\ncarefully to identify the webinar(s) appropriate for their specific training needs.\nQuestions\nAll questions regarding training webinars should be directed to the eMedNY Call Center at (800) 343-9000.\n***************************************************************************************************************\neMedNY Provider Training Videos Available\neMedNY offers recorded training videos on a variety of topics that allow providers and staff an alternative\nlearning option that is easy to access and availa", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0006", "char_start": 6300, "char_end": 7500, "pages": [3], "text": "offers recorded training videos on a variety of topics that allow providers and staff an alternative\nlearning option that is easy to access and available online. Providers and staff can learn at their own pace\nand access training content via computer or telephone, at any time. Webinars currently available include, but\nare not limited to:\n• ePACES: Eligibility Request and Response, User Administration, and Claim Balancing\n• New Provider / New Biller: Edit/Error Knowledge Base (EEKB): Denied and Pended Claims, Keeping\nup-to-date, Medicaid Partners, Medicaid Update, and Pre-Adjudication Crosswalk (Rejected Claims)\n• eMedNY Provider Enrollment Portal: PE Portal for Practitioners and Wage Parity Attestation\nTo view the list of recorded training videos, providers should visit the eMedNY “Provider Training Videos” web\npage, located at: https://www.emedny.org/training/videos.aspx. eMedNY strongly encourages providers to\ncontinually monitor the web page for new recorded training videos.\nQuestions\nAll questions regarding recorded training videos should be directed to the eMedNY Call Center at (800) 343-\n9000.\n***********************************************************************************", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0007", "char_start": 7350, "char_end": 8550, "pages": [3, 4], "text": "s should be directed to the eMedNY Call Center at (800) 343-\n9000.\n***************************************************************************************************************\nNovember 2022 New York State Medicaid Update pg. 3\n\nReminder to Dental Providers on the Use of Antibiotics in Dentistry\nThe Centers for Disease Control (CDC) has designated Friday, November 18, 2022, through Thursday,\nNovember 24, 2022, as United States Antibiotic Awareness Week (USAAW) to highlight the importance of\nimproving antibiotic prescribing and use, also known as antibiotic stewardship.\nDental providers are uniquely positioned to play a role in minimizing antibiotic overuse. According to the\nAntimicrobial stewardship in dental practice article published on the Journal of the American Dental\nAssociation (JADA) website, located at: https://jada.ada.org/action/showPdf?pii=S0002-8177%2820%\n2930320-2#relatedArticles, “dental antibiotic prescribing contributes to approximately 10 percent of all\nantibiotic prescriptions, and an estimated 80 percent of that prescribing is deemed inappropriate.” To limit\nadverse reactions and drug resistance, the CDC stresses evidence-based prescribing on a documented\ndiag", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0008", "char_start": 8400, "char_end": 9600, "pages": [4], "text": "prescribing is deemed inappropriate.” To limit\nadverse reactions and drug resistance, the CDC stresses evidence-based prescribing on a documented\ndiagnosis, as well as using the most targeted (narrow-spectrum) antibiotic for the shortest duration possible.\nThe American Dental Association (ADA) Antibiotic Prophylaxis Prior to Dental Procedures, located at:\nhttps://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/antibiotic-prophy\nlaxis, and the American Heart Association (AHA) Prevention of Viridans Group Streptococcal Infective\nEndocarditis document, located at: https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000969,\nsupport premedication for a relatively small subset of patients.\nIn general, patients with prosthetic joints undergoing dental procedures should not take prophylactic\nantibiotics to prevent prosthetic joint infection. The ADA recommends a complete health history and\nconsultation with both the patient and orthopedic surgeon, per the ADA management of patients with\nprosthetic joints undergoing dental procedures document, located at: https://www.ada.org/-\n/media/project/ada-organization/ada/ada-org/files/resources/research/ada_cha", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0009", "char_start": 9450, "char_end": 10650, "pages": [4], "text": " undergoing dental procedures document, located at: https://www.ada.org/-\n/media/project/ada-organization/ada/ada-org/files/resources/research/ada_chairside_guide_prosthetics.pdf?\nrev=848d32fce4d1484299d05bbb50f060b9&hash=2ECD50BD260BDC98EDCAF9569B969747, for patients\nwith a history of complications associated with their joint replacement. In cases where antibiotics are deemed\nnecessary, it is most appropriate that the orthopedic surgeon recommend the appropriate antibiotic regimen\nand when reasonable, write the prescription.\nQuestions and Additional Information:\n• For a complete summary of the current recommendations for antibiotic prophylaxis prior to dental\nprocedures, dental providers should refer to the ADA Antibiotic Prophylaxis Prior to Dental Procedures,\nlocated at: https://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/\nantibiotic-prophylaxis. Reviewing these criteria and guidelines can assist in avoiding unnecessary\nprescribing which can help minimize the risk of adverse effects and development of drug-resistant\nbacteria.\n• New York State (NYS) Department of Health (DOH) resources regarding antibiotic resistance:\nNew York State Department", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0010", "char_start": 10500, "char_end": 11700, "pages": [4, 5], "text": "ent of drug-resistant\nbacteria.\n• New York State (NYS) Department of Health (DOH) resources regarding antibiotic resistance:\nNew York State Department of Health Issues Poster to Raise Awareness About Proper Antibiotics\nUse in Recognition of U.S. Antibiotic Awareness Week press release, located at:\nhttps://health.ny.gov/press/releases/2022/2022-11-01_antibiotic_awareness_week.htm.\n Dental providers can order the winning “Andy-Biotic” Superbug Superheroes poster,\nlocated at: https://health.ny.gov/publications/12035.pdf, in bulk, by completing and\nsubmitting the Superbug Superheroes Poster Request Form, located at:\nhttps://health.ny.gov/professionals/protocols_and_guidelines/antibiotic_resistance/docs/p\noster_oder_form.pdf.\n• NYS Medicaid fee-for-service (FFS) coverage and policy questions should be directed to the Office of\nHealth Insurance Programs (OHIP) Division of Program Development and Management (DPDM) by\ntelephone at (518) 473-2160 or by email at dentalpolicy@health.ny.gov.\n***************************************************************************************************************\nNovember 2022 New York State Medicaid Update pg. 4\n\nUnderstanding How Adverse Childhood Expe", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0011", "char_start": 11550, "char_end": 12750, "pages": [4, 5], "text": "*********************************************************\nNovember 2022 New York State Medicaid Update pg. 4\n\nUnderstanding How Adverse Childhood Experiences Affect Patients’\nHealth Across the Lifespan\nAdverse Childhood Experiences (ACEs) are stressful or traumatic events, such as neglect and/or violence\nduring childhood. ACEs are strongly related to brain development and a wide range of health problems\nthroughout a person’s lifetime and may include, but are not limited to, physical or sexual abuse, domestic\nviolence, living in poverty, death of a caregiver, exposure to discrimination, or living in a household with\nsomeone with mental illness, substance use disorder, or who has experienced incarceration. ACEs research\nhas shown:\n• When families experience historical and systemic racism or live in poverty for generations, the effects\nof ACEs can add up over time.\n• ACEs are very common in every population group.\n• ACEs can have significant impact on a child’s ability to succeed in school, causing a negative impact\non their mental health and general well-being.\n• Adults who have experienced ACEs can have higher rates of negative health outcomes, including\ndepression, obesity, substan", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0012", "char_start": 12600, "char_end": 13800, "pages": [5], "text": "h and general well-being.\n• Adults who have experienced ACEs can have higher rates of negative health outcomes, including\ndepression, obesity, substance abuse, anxiety, smoking, and early death.\nParental and child resilience have been shown to reduce the negative impacts of ACEs. Protective factors\nthat may boost child or parental resilience may include, but are not limited to:\n• supportive and caring relationships and social connections;\n• programs that understand a person’s background and culture;\n• a healthy lifestyle, which may include regular exercise, mindfulness, getting sufficient sleep, and eating\na healthy and nutritious diet;\n• economic support/stability for families; and\n• quality childcare and education early in life.\nNew York State (NYS) Office of Children and Family Services (OCFS) has developed materials for providers\nto share this information with adult patients, parents, and caregivers, such as a brochure titled Understanding\nadverse childhood experiences (ACEs), which is available in multiple languages on the NYS OCFS\n“Publications” web page: https://ocfs.ny.gov/publications/index.php?find=Pub.+5222.\nAdditional Information\nVisit the NYS OCFS “Adverse Childhood Ex", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0013", "char_start": 13650, "char_end": 14850, "pages": [5, 6], "text": "FS\n“Publications” web page: https://ocfs.ny.gov/publications/index.php?find=Pub.+5222.\nAdditional Information\nVisit the NYS OCFS “Adverse Childhood Experiences (ACEs)” web page, located at:\nhttps://ocfs.ny.gov/programs/cwcs/aces.php, for additional information and resources.\n***************************************************************************************************************\nNovember 2022 New York State Medicaid Update pg. 5\n\nNational Cancer Institute-Designated Cancer Centers\nNew York State (NYS) Social Services Law (SSL) §364-J(4) paragraph (w), located at:\nhttps://www.nysenate.gov/legislation/laws/SOS/364-J, requires health plans offering New York State (NYS)\nMedicaid, Essential Plan (EP) and Qualified Health Plan (QHP) to contract with willing National Cancer\nInstitute (NCI)-designated cancer centers. Effective January 1, 2023, Medicaid Managed Care (MMC) Plans,\nincluding mainstream MMC Plans, Human Immunodeficiency Virus-Special Needs Plans (HIV-SNPs), and\nHealth and Recovery Plans (HARPs), will be required to contract with willing NCI-designated cancer centers\nin their service areas. A list of NYS cancer centers can be found on the NCI “Find a Cancer Center” web\npag", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0014", "char_start": 14700, "char_end": 15900, "pages": [6, 7], "text": "with willing NCI-designated cancer centers\nin their service areas. A list of NYS cancer centers can be found on the NCI “Find a Cancer Center” web\npage, located at: https://www.cancer.gov/research/infrastructure/cancer-centers/find, by utilizing the “Find\nCancer Centers listed by state” feature.\nProviders should contact the MMC enrollees’ health plan for a list of the NCI-designated cancer centers in the\nhealth plan’s network.\nQuestions and Additional Information:\n• MMC enrollment, reimbursement, billing and/or documentation requirement questions should be\ndirected to the enrollee’s specific MMC Plan.\n• MMC Plan contact information/plan directory can be found in the eMedNY New York State Medicaid\nProgram Information for All Providers – Managed Care Information document, located at:\nhttps://www.emedny.org/ProviderManuals/AllProviders/PDFS/Information_for_All_Providers_Manag\ned_Care_Information.pdf.\n***************************************************************************************************************\nNovember 2022 New York State Medicaid Update pg. 6\n\nPolicy and Billing\nReminder: Medicaid Billing Rules\nfor Family Planning and Reproductive Health Services\nProviders participat", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0015", "char_start": 15750, "char_end": 16950, "pages": [6, 7], "text": "e Medicaid Update pg. 6\n\nPolicy and Billing\nReminder: Medicaid Billing Rules\nfor Family Planning and Reproductive Health Services\nProviders participating in the provider network of a Medicaid Managed Care (MMC) Plan should bill family\nplanning and reproductive health services to the relevant MMC Plan and not to Medicaid fee-for-service\n(FFS). All MMC Plans [including mainstream MMC Plans, Human Immunodeficiency Virus-Special Needs\nPlans (HIV-SNPs) and Health and Recovery Plans (HARPs)] include family planning and reproductive health\nservices within their benefit package.\nMMC Plans\nMMC Plans should offer provider outreach to ensure contracted providers are aware to bill the MMC Plan for\ncovered services provided to MMC enrollees for benefit package services, including family planning and\nreproductive health services.\nProviders\nMedicaid FFS\nAll providers should ensure that MMC Plans are billed for family planning and reproductive health services\nprovided to MMC enrollees (providers must have a contract with the MMC enrollees MMC Plan in order to do\nso). Please note: Effective January 1, 2019, Fidelis Care includes family planning and reproductive health\nservices in the benefit packag", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0016", "char_start": 16800, "char_end": 18000, "pages": [7], "text": " order to do\nso). Please note: Effective January 1, 2019, Fidelis Care includes family planning and reproductive health\nservices in the benefit package for NYS Medicaid members. Previously, Medicaid FFS had provided this\nbenefit for Fidelis Care members. Effective January 1, 2019, participating Fidelis Care providers should bill\nfamily planning and reproductive health services to Fidelis Care, not Medicaid FFS.\nMedicaid\nMMC enrollees may obtain family planning and reproductive health services from any qualified Medicaid\nprovider. The following services provided to a MMC enrollee by an out-of-network provider should be billed\nto Medicaid FFS:\n• birth control drugs and devices, including Intrauterine Devices (IUDs), diaphragms, and other kinds of\nbirth control;\n• emergency contraception;\n• sterilization for men and women;\n• pregnancy testing;\n• an abortion that the patient and provider agree is needed;\n• HIV and sexually transmitted disease (STD) testing, treatment, counseling; and\n• screenings for cancer and other related problems.\nQuestions and Additional Information:\n• MMC enrollment, reimbursement, billing and/or documentation requirement questions should be\ndirected to the enrol", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0017", "char_start": 17850, "char_end": 19050, "pages": [7, 8], "text": "stions and Additional Information:\n• MMC enrollment, reimbursement, billing and/or documentation requirement questions should be\ndirected to the enrollee’s specific MMC Plan. Providers can refer to the eMedNY New York State\nMedicaid Program Information for All Providers: Managed Care Information document, located at:\nhttps://www.emedny.org/ProviderManuals/AllProviders/PDFS/Information_for_All_Providers_Manag\ned_Care_Information.pdf, for contact information per MMC Plan.\n• Medicaid FFS billing/claim questions should be directed to the eMedNY Call Center at (800) 343-\n9000.\n***************************************************************************************************************\nNovember 2022 New York State Medicaid Update pg. 7\n\nSystem Requirements for Compounded Prescriptions\nEffective December 22, 2022, the NYRx Pharmacy program, formerly known as the New York State (NYS)\nMedicaid Pharmacy program, will require a valid route of administration code for all compounded prescription\nclaims submitted via the National Council for Prescription Drug Programs (NCPDP) D.0 format. NCPDP\nutilizes Systematized Nomenclature of Medicine -- Clinical Terms (SNOMED CT) terminology for the rout", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0018", "char_start": 18900, "char_end": 20100, "pages": [8], "text": "cription Drug Programs (NCPDP) D.0 format. NCPDP\nutilizes Systematized Nomenclature of Medicine -- Clinical Terms (SNOMED CT) terminology for the route of\nadministration, which will be required in field 995-E2 (Route of Administration).\nNYS Medicaid will further verify the compound ingredients submitted in NCPDP field 489-TE (Compound\nProduct ID) are valid for the submitted route of administration. Claims submitted with missing or invalid data\nin these fields will deny with the following message:\neMedNY Edit Number/Message NCPDP Response Code/Description\n02337 – Invalid SNOMED to Route Code Mapping E2 – M/I Route of Administration\nQuestions and Additional Information:\n• Questions regarding claim submission should be directed to the eMedNY Call Center at\n(800) 343 9000.\n• Policy-related questions should be directed to the Medicaid Pharmacy Policy Department at\n‑\n(518) 486 3209 or NYRx@health.ny.gov.\n******************\n‑\n*********************************************************************************************\nMpox (formerly known as Monkeypox) Services No Longer Exempt\nfrom Medicaid Copayments\nEffective October 28, 2022, in accordance with the expiration of New York State (NYS) G", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0019", "char_start": 19950, "char_end": 21150, "pages": [8], "text": " Monkeypox) Services No Longer Exempt\nfrom Medicaid Copayments\nEffective October 28, 2022, in accordance with the expiration of New York State (NYS) Governor Kathy\nHochul’s Executive Order 20.2 titled Continuing the Declaration of a Statewide Disaster Emergency due the\nOngoing Spread of the Monkeypox Virus in the State of New York, located at:\nhttps://www.governor.ny.gov/executive-order/no-202-continuing-declaration-statewide-disaster-emergency-\ndue-ongoing-spread, mpox (formerly known as the monkeypox) vaccine administration, lab testing, and initial\ndiagnostic evaluations provided to NYS Medicaid fee-for-service (FFS) members and Medicaid Managed\nCare (MMC) enrollees are subject to NYS Medicaid copayments, when applicable. NYS Medicaid FFS\nproviders should disregard billing instructions provided in the Copayments Waived for Monkeypox Diagnostic\nEvaluations, Vaccine Administration, and Testing article, published in the August 2022 issue of the Medicaid\nUpdate, located at: https://www.health.ny.gov/health_care/medicaid/program/update/2022/docs/mu_no9\n_aug22_pr.pdf.\nQuestions and Additional Information:\n• FFS coverage and policy questions should be directed to the Office of Health I", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0020", "char_start": 21000, "char_end": 22200, "pages": [8, 9], "text": "2022/docs/mu_no9\n_aug22_pr.pdf.\nQuestions and Additional Information:\n• FFS coverage and policy questions should be directed to the Office of Health Insurance Programs\n(OHIP) Division of Program Development and Management (DPDM) by telephone at (518) 473-2160\nor by email at FFSMedicaidPolicy@health.ny.gov.\n• FFS claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to the\nenrollee's MMC Plan.\n• MMC Plan contact information can be found in the eMedNY New York State Medicaid Program\nInformation for All Providers Managed Care Information document, located at:\nhttps://www.emedny.org/ProviderManuals/AllProviders/PDFS/Information_for_All_Providers_Manag\ned_Care_Information.pdf.\nNovember 2022 New York State Medicaid Update pg. 8\n\nPharmacy\nUpdates to Medicaid Fee-for-Service Practitioner Administered Drug\nPolicies and Billing Guidance\nOn July 14, 2022, the New York State (NYS) Medicaid Drug Utilization Review (DUR) Board recommended\ncoverage policies for several practitioner administered drugs (PADs), which resulted in a meeting summary\ninclusive of the recommendations and ", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0021", "char_start": 22050, "char_end": 23250, "pages": [9], "text": "mended\ncoverage policies for several practitioner administered drugs (PADs), which resulted in a meeting summary\ninclusive of the recommendations and final determination by the Commissioner of Health. Providers can refer\nto the NYS Department of Health (DOH) “Drug Utilization Review (DUR) Board - 2022” web page, located at:\nhttps://www.health.ny.gov/health_care/medicaid/program/dur/meetings/2022/, for the full-July 14, 2022\nmeeting summary. Additionally, NYS Medicaid Pharmacy program prior authorization (PA) changes were\nannounced during the July 14, 2022 meeting, which are outlined in the Medicaid Pharmacy Prior Authorization\nPrograms Update article of the October 2022 issue Medicaid Update, located at: https://www.health.ny. gov/\nhealth_care/medicaid/program/update/2022/docs/mu_no12_oct22_pr.pdf.\nEffective December 29, 2022, criteria for aducanumab-avwa (Adulhelm®), botulinum toxins (Dysport®,\nXeomin®, Botox®, and Myobloc®), infliximab (Remicade®) and its biosimilars, and vedolizumab (Entyvio®)\nare as follows:\nAducanumab-avwa (Aduhelm®)\nBefore initiating aducanumab-avwa (Aduhelm®), prescribers must attest that the patient has been diagnosed\nwith mild cognitive impairment due to A", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0022", "char_start": 23100, "char_end": 24300, "pages": [9], "text": "lm®)\nBefore initiating aducanumab-avwa (Aduhelm®), prescribers must attest that the patient has been diagnosed\nwith mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia by meeting one of\nthe following scores:\n• Clinical Dementia Rating (CDR)-Global Score of 0.5 to 1\n• Mini-Mental Status Exam (MMSE) score between 24 and 30\n• Montreal Cognitive Assessment (MoCA) score of at least 18\nBefore initiating aducanumab-avwa (Aduhelm®), prescribers must provide medical records for the following\npre-treatment testing:\n• genetic testing to assess apolipoprotein E ε4 carrier status, and\n• positron emission tomography (PET) scan or cerebrospinal fluid (CSF) analysis to confirm the\npresence of amyloid beta deposits.\nBefore initiating aducanumab-avwa (Aduhelm®), prescribers must attest that the patient does not have\nevidence of any medical or neurological condition other than Alzheimer’s disease that could be contributing\nto the patient’s cognitive impairment.\nBefore initiating aducanumab-avwa (Aduhelm®), prescribers must attest that the patient does not have a\nhistory of a clotting disorder and is not taking any form of antiplatelet or anticoagulant medications other t", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0023", "char_start": 24150, "char_end": 25350, "pages": [9, 10], "text": "attest that the patient does not have a\nhistory of a clotting disorder and is not taking any form of antiplatelet or anticoagulant medications other than\naspirin ≤325 mg/day.\nFor continuation of therapy, providers must attest that the patient’s score remained stable or improved,\nutilizing the same baseline assessment tool as outlined for initiation of therapy.\nNovember 2022 New York State Medicaid Update pg. 9\n\nBotulinum Toxins\nStep Therapy (ST) Requirements*\nIndication ST\nChronic sialorrhea** Glycopyrrolate\nHeadache prevention in patients with chronic Two oral agents FDA-approved or compendia-supported\nmigraine for prevention of migraine\nOveractive bladder Antimuscarinic agent or beta-3-adrenoceptor agonist\nNeurogenic detrusor overactivity*** Antimuscarinic agent\nUrinary incontinence due to detrusor overactivity Antimuscarinic agent or beta-3-adrenoceptor agonist\n*Requires a trial of a drug to treat a condition before initiating another therapy for the same condition.\n**Excludes patients with Parkinson’s disease and other neurodegenerative diseases.\n***Excludes patients with multiple sclerosis (MS) or spinal cord injury.\nInfliximab (Remicade®), infliximab-abda (Renflexis®), inflix", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0024", "char_start": 25200, "char_end": 26400, "pages": [10], "text": "rative diseases.\n***Excludes patients with multiple sclerosis (MS) or spinal cord injury.\nInfliximab (Remicade®), infliximab-abda (Renflexis®), infliximab-axxq (Avsola™), and\ninfliximab-dyyb (Inflectra®)\nTrial of a disease-modifying anti-rheumatic drug (DMARD) or tumor necrosis factor inhibitor (TNFi) Food and\nDrug Administration (FDA)-approved for self-administration prior to initiation of infliximab (Remicade®).\nVedolizumab (Entyvio®)\nTrial of a DMARD or TNFi prior to initiation of vedolizumab (Entyvio®).\nBilling\nFee-for-Service\nFor NYS Medicaid fee-for-service (FFS), Clinical Criteria Worksheets can be found on the NYS DOH “New\nYork State Medicaid Fee-for-Service Practitioner Administered Drug Policies and Billing Guidance” web page,\nlocated at: https://www.health.ny.gov/health_care/medicaid/program/practitioner_administered/ffs_pract\nitioner_administer.htm.\nPractitioners\nA practitioner can obtain the applicable Healthcare Common Procedure Code System (HCPCS) code for the\ndrug using the Fee Schedule listed in the eMedNY NYS Medicaid Program Physician - Procedure Codes,\nSection 2 - Medicine, Drugs and Drug Administration manual, located at: https://www.emedny\n.org/ProviderManuals", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0025", "char_start": 26250, "char_end": 27450, "pages": [10, 11], "text": "d Program Physician - Procedure Codes,\nSection 2 - Medicine, Drugs and Drug Administration manual, located at: https://www.emedny\n.org/ProviderManuals/Physician/PDFS/Physician_Procedure_Codes_Sect2.pdf. The associated National\nDrug Codes (NDCs) must be included on the claim.\nClinics\nClinics must bill an ordered ambulatory claim as well as submit the claim on paper using the Medical\nAssistance Health Insurance Claim Form (eMedNY 150003 form), located at: https://www.\nemedny.org/info/phase2/PDFS/eMedNY_150003.pdf. Billing guidelines can be found in the eMedNY New\nYork State 150003 Billing Guidelines - Free Standing or Hospital Based Ordered Ambulatory, located at:\nhttps://www.emedny.org/ProviderManuals/OrderedAmbulatory/PDFS/OrderedAmbulatory_Billing_Guideline\ns.pdf.\nNovember 2022 New York State Medicaid Update pg. 10\n\nQuestions and Additional Information:\n• FFS billing and claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• FFS Pharmacy and PAD coverage policy questions should be directed to the Medicaid Pharmacy\nPolicy Unit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n• Additional information on the DUR Board is available on the NY", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0026", "char_start": 27300, "char_end": 28500, "pages": [11], "text": "harmacy\nPolicy Unit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n• Additional information on the DUR Board is available on the NYS Department of Health (DOH) “Drug\nUtilization Review (DUR)” web page, located at: http://www.health.ny.gov/health_care/medicaid\n/program/dur/index.htm.\n• Practitioner administered drug Clinical Criteria Worksheets can be found on the NYS DOH “New York\nState Medicaid Fee-for-Service Practitioner Administered Drug Policies and Billing Guidance” web\npage, located at: https://www.health.ny.gov/health_care/medicaid/program/practitioner_administered\n/ffs_practitioner_administer.htm.\n• Additional information is also available at the following websites:\nNYS DOH “Welcome to NYRx, the Medicaid Pharmacy Program” web page\n(https://www.health.ny.gov/health_care/medicaid/program/pharmacy.htm)\nNYS DOH website (https://www.health.ny.gov)\neMedNY website (http://www.eMedNY.org)\n***************************************************************************************************************\nReminder: Pharmacy Dispensing of Emergency Contraceptives\nPer the Pharmacy Reminder: Emergency Contraceptive Coverage article published in the April 2019 issue of\nthe", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0027", "char_start": 28350, "char_end": 29550, "pages": [11], "text": "cy Dispensing of Emergency Contraceptives\nPer the Pharmacy Reminder: Emergency Contraceptive Coverage article published in the April 2019 issue of\nthe Medicaid Update, located at: https://www.health.ny.gov/health_care/medicaid/program/update\n/2019/apr19_mu.pdf, New York State (NYS) Medicaid covers both prescription and over-the-counter (OTC)\nemergency contraception for members enrolled in NYRx, formerly known as the NYS Medicaid Pharmacy\nprogram, and Medicaid Managed Care (MMC) enrollees. OTC emergency contraception can be prescribed\nby a practitioner or dispensed without a fiscal order when requested by the member in accordance with New\nYork Codes, Rules, and Regulations (NYCRR), Title 18, §505.3. OTC emergency contraceptive billing\nguidance for NYRx can be found in the Reminder: Pharmacy Dispensing Non-Patient Specific Orders article\npublished in the January 2022 issue of the Medicaid Update, located at: https://www.health.ny.gov\n/health_care/medicaid/program/update/2022/docs/mu_no1_jan22_pr.pdf.\nPlease note: Prescription-only emergency contraceptives [e.g., ulipristal (ella®)] may be dispensed\nonly pursuant to a patient specific order.\nA pharmacy, in compliance with NYS law and ", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0028", "char_start": 29400, "char_end": 30600, "pages": [11, 12], "text": "ency contraceptives [e.g., ulipristal (ella®)] may be dispensed\nonly pursuant to a patient specific order.\nA pharmacy, in compliance with NYS law and regulations, may dispense and submit a claim for emergency\ncontraceptives when the following apply:\n• a prescriber submits a prescription order for either the OTC or prescription-only emergency\ncontraceptive; or\n• a NYRx member or MMC enrollee specifically requests the OTC emergency contraceptive item on the\ndate of service; and\n• a pharmacy submits one course of therapy with no refills; and\n• the drug item(s) are dispensed according to:\nFood and Drug Administration (FDA) guidelines,\nNYS laws, rules, and regulations, and\nNYS Medicaid policy.\nNovember 2022 New York State Medicaid Update pg. 11\n\nThe following table illustrates the prescribing requirements of both prescription and OTC emergency\ncontraceptive products.\nNational Council for Prescription-Only Emergency OTC Emergency Contraceptive\nPrescription Drug Contraceptive\nPrograms (NCPDP) D.0. NYRx MMC NYRx MMC\nClaim Segment Field*\n444-E9 (Pharmacist ID) Not Applicable Consult MMC Enter Pharmacist Consult MMC\nNPI number\n411-DB (Prescriber ID) Qualified Qualified Leave Blank or Consult", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0029", "char_start": 30450, "char_end": 31650, "pages": [12], "text": "9 (Pharmacist ID) Not Applicable Consult MMC Enter Pharmacist Consult MMC\nNPI number\n411-DB (Prescriber ID) Qualified Qualified Leave Blank or Consult MMC\nPractitioner Practitioner enter Qualified\nNational Provider NPI number Practitioner NPI\nIdentifier (NPI) number\nnumber\nPlease note: Providers can refer to the Matching Origin Codes to Correct Prescription Serial Number in\nMedicaid Fee-for-Service article published in the July 2020 issue of the Medicaid Update, located at:\nhttps://www.health.ny.gov/health_care/medicaid/program/update/2020/docs/mu_no12_jul20.pdf, for\nguidance on origin code and serial number values that must be submitted on NYRx claims.\nQuestions and Additional Information:\n• NYRx claim questions should be directed to the eMedNY Call Center at (800) 343-9000.\n• NYRx pharmacy coverage and policy questions should be directed to the Medicaid Pharmacy Policy\nUnit by telephone at (518) 486-3209 or by email at NYRx@health.ny.gov.\n• MMC reimbursement, billing, and/or documentation requirement questions should be directed to\nenrollee MMC Plan.\n• MMC Plan contact information can be found in the eMedNY New York State Medicaid Program\nInformation for All Providers Managed Car", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0030", "char_start": 31500, "char_end": 32700, "pages": [12, 13], "text": "enrollee MMC Plan.\n• MMC Plan contact information can be found in the eMedNY New York State Medicaid Program\nInformation for All Providers Managed Care Information document, located at:\nhttps://www.emedny.org/ProviderManuals/AllProviders/PDFS/Information_for_All_Providers_Manag\ned_Care_Information.pdf.\n***************************************************************************************************************\nNovember 2022 New York State Medicaid Update pg. 12\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud, waste, or abuse complaints/allegations, please call 1-877-87FRAUD, (877) 873-7283,\nor visit the Office of Medicaid Inspector General (OMIG) web site at: www.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at: www.emedny.org.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nPlease enroll online for a provider seminar ", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0031", "char_start": 32550, "char_end": 33750, "pages": [13], "text": "nd performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nPlease enroll online for a provider seminar at: https://www.emedny.org/training/index.aspx. For individual\ntraining requests, please call (800) 343-9000.\nBeneficiary Eligibility:\nPlease call the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following web sites:\n• DOH Prescriber Education Program page:\nhttps://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-educationprog.\n• Prescriber Education Program in partnership with SUNY: http://nypep.nysdoh.suny.edu/.\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit the eMedNY Provider\nEnrollment page at: https://www.emedny.org/info/ProviderEnrollment/index.aspx, and choose the\nappropriate link based on provider type.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0032", "char_start": 33600, "char_end": 33802, "pages": [13], "text": " based on provider type.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nNovember 2022 New York State Medicaid Update pg. 13", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0033", "char_start": 33652, "char_end": 33802, "pages": [13], "text": "garding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nNovember 2022 New York State Medicaid Update pg. 13", "chunk_type": "text", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0034::table", "char_start": null, "char_end": null, "pages": [8], "text": ",\r\neMedNY Edit Number/Message,NCPDP Response Code/Description\r\n,\r\n02337 – Invalid SNOMED to Route Code Mapping,E2 – M/I Route of Administration\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0035::table", "char_start": null, "char_end": null, "pages": [10], "text": ",Indication,,,ST,\r\nChronic sialorrhea**,,,Glycopyrrolate,,\r\n\"Headache prevention in patients with chronic\nmigraine\",,,\"Two oral agents FDA-approved or compendia-supported\nfor prevention of migraine\",,\r\nOveractive bladder,,,Antimuscarinic agent or beta-3-adrenoceptor agonist,,\r\nNeurogenic detrusor overactivity***,,,Antimuscarinic agent,,\r\nUrinary incontinence due to detrusor overactivity,,,Antimuscarinic agent or beta-3-adrenoceptor agonist,,\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0036::table", "char_start": null, "char_end": null, "pages": [10], "text": "Clinics must bill an ordered ambulatory claim as well as submit the claim on paper using the Medical\r\n\"Assistance Health Insurance Claim Form (eMedNY 150003 form), located at: https://www.\"\r\nemedny.org/info/phase2/PDFS/eMedNY_150003.pdf. Billing guidelines can be found in the\r\n", "chunk_type": "table", "category": "Medicaid Update"}
{"doc_id": "mu_no13_nov22_pr.pdf", "chunk_id": "mu_no13_nov22_pr.pdf::0037::table", "char_start": null, "char_end": null, "pages": [12], "text": ",National Council for,,,Prescription-Only Emergency,,,,OTC Emergency Contraceptive,\r\n,Prescription Drug,,,Contraceptive,,,,,\r\n,Programs (NCPDP) D.0.,,NYRx,NYRx,MMC,MMC,,NYRx,MMC\r\n,Claim Segment Field*,,,,,,,,\r\n444-E9 (Pharmacist ID),,,Not Applicable,,Consult MMC,,,\"Enter Pharmacist\nNPI number\",Consult MMC\r\n411-DB (Prescriber ID),,,\"Qualified\nPractitioner\nNational Provider\nIdentifier (NPI)\nnumber\",,\"Qualified\nPractitioner\nNPI number\",,,\"Leave Blank or\nenter Qualified\nPractitioner NPI\nnumber\",Consult MMC\r\n", "chunk_type": "table", "category": "Medicaid Update"}
